Imfinzi.com

Website Ranking Data
Current Alexa Rank

431,506

Updated Jan 31 2023
Historical Rank
Estimated Visitors

7,072

Daily Unique Visitors

219,224

Monthly Visitors

2,630,688

Yearly Visitors
Name Server Information
ns-1417.awsdns-49.org
ns-151.awsdns-18.com
ns-1705.awsdns-21.co.uk
ns-724.awsdns-26.net
Web Server Information
IP Address 13.33.74.34
Server Response 200
Web Server astrazeneca.com
Top related sites:
Meta Tags and Data
Title
Immunotherapy for Advanced Bladder Cancer | For Patients | IMFINZI™ (durvalumab)
Meta Description
IMFINZI™ (durvalumab) is an immunotherapy used to treat a type of cancer in the bladder and urinary tract called urothelial carcinoma. Learn more about IMFINZI.
Meta Keywords
Technologies in use
Google Analytics, jQuery, jQuery UI, Modernizr, SiteCatalyst, Underscore.js
Server Response
Content-Typetext/html; charset=UTF-8
Connectionkeep-alive
Access-Control-Allow-Originhttps://policy.cookiereports.com,http://www.imfinzi.com
Cache-Controlno-cache="set-cookie"
Content-Encodinggzip
ExpiresThu, 01 Jan 1970 00:00:00 GMT
Serverastrazeneca.com
X-Content-Type-Optionsnosniff
X-Frame-OptionsSAMEORIGIN
X-Powered-ByAstrazeneca
X-XSS-Protection1; mode=block
VaryAccept-Encoding,User-Agent
X-CacheMiss from cloudfront
Via1.1 accd17b9e81974748fb925f0caaec427.cloudfront.net (CloudFront)
X-Amz-Cf-IdmyHpiHHe8zDpjDtriXlsedSWG_jP5BzUEI_2tskuQvaDGAfqipU2pQ==